The Sinonasal Outcome Test–22 or European Position Paper: Which Is More Indicative of Imaging Results?

Objective The 22‐item Sinonasal Outcome Test (SNOT‐22) is a trusted measure of symptom severity in chronic rhinosinusitis. The European Position Paper on Rhinosinusitis (EPOS) provides widely accepted diagnostic criteria, which include sinonasal symptoms, their duration, and imaging results. Our objective was to compare these approaches to assessing symptoms to determine if either was more indicative of radiologic findings, to support decisions in telehealth. Study Design Observational outcomes study. Setting Tertiary care center. Methods In total, 162 consecutive patients provided a structured sinonasal history, completed the SNOT‐22, and underwent sinus computed tomography (CT) within 1 month. SNOT‐22 scores, EPOS‐defined symptom sets, and Lund‐Mackay results were assessed. To facilitate direct comparisons, we performed stepwise evaluations of sinonasal symptoms alone and combined with duration. The discriminatory capacity for imaging results was determined through areas under the receiver operating characteristic curves (ROC‐AUC) for dichotomous outcomes and ordinal regression for multilevel outcomes. Results In ROC‐AUC analyses, SNOT‐22 and EPOS‐defined symptoms had similar discriminatory capacity for Lund‐Mackay scores, regardless of duration. Within ordinal regression analyses, SNOT‐22 nasal scores were significantly associated with Lund‐Mackay scores, while EPOS‐defined nasal symptoms were not statistically significantly related. Conclusions SNOT‐22 nasal scores and EPOS‐defined nasal symptoms may have similar associations with imaging results when assessed via ROC‐AUC, while SNOT‐22 may have more association within ordinal data. Understanding the implications of discrete patterns of symptoms may confer benefit, particularly when in‐person and fiberoptic exams are limited.